What is PEGUS Research?
PEGUS Research operates at the intersection of clinical research and pharmacy practice, pioneering the use of community pharmacies as primary enrollment sites. This model, which utilizes pharmacists as principal investigators, has proven instrumental in executing complex self-selection and actual use studies. The firm is widely recognized for its agility and leadership in the Rx-to-OTC switch space, having successfully facilitated landmark trials in the United Kingdom. By maintaining an extensive, trained network of pharmacy sites, PEGUS Research provides a scalable and efficient infrastructure for pharmaceutical companies navigating the rigorous demands of modern clinical trials.
How much funding has PEGUS Research raised?
PEGUS Research has raised a total of $977K across 2 funding rounds:
Debt
$350K
Debt
$627K
Debt (2020): $350K with participation from PPP
Debt (2021): $627K led by PPP
Key Investors in PEGUS Research
PPP
Public-Private Partnership
What's next for PEGUS Research?
With this major enterprise-level funding, PEGUS Research is well-positioned to scale its proprietary pharmacy-based trial network and enhance its technological capabilities for data collection. The strategic focus will likely shift toward expanding its geographic footprint and deepening its service offerings for global pharmaceutical clients. As the industry moves toward more decentralized clinical trial models, PEGUS Research's established infrastructure provides a significant competitive advantage. The company is expected to leverage this capital to further refine its research methodologies, ensuring it remains at the forefront of the evolving clinical research landscape while maintaining the high standards of agility and innovation that have defined its growth trajectory to date.
See full PEGUS Research company page
